142 related articles for article (PubMed ID: 36042611)
1. Comparison of antimicrobial resistance in patients with obstructive pyelonephritis associated with ureteral stones and uncomplicated pyelonephritis.
Jang YR; Won J; Han J; Chung W; Ahn SJ
Medicine (Baltimore); 2022 Aug; 101(34):e30376. PubMed ID: 36042611
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.
Kim SH; Oh S; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):937-944. PubMed ID: 30868326
[TBL] [Abstract][Full Text] [Related]
5. Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women.
Wie SH; Kim HW; Chang UI
Clin Microbiol Infect; 2014 Nov; 20(11):1211-8. PubMed ID: 24909648
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
[TBL] [Abstract][Full Text] [Related]
7. Prolonged fever is not a reason to change antibiotics among patients with uncomplicated community-acquired acute pyelonephritis.
Jang YR; Eom JS; Chung W; Cho YK
Medicine (Baltimore); 2019 Oct; 98(43):e17720. PubMed ID: 31651906
[TBL] [Abstract][Full Text] [Related]
8. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.
Kim SH; Lim KR; Lee H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):159-167. PubMed ID: 31520270
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
Chang UI; Kim HW; Noh YS; Wie SH
Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
[TBL] [Abstract][Full Text] [Related]
11. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
Wie SH; Kim HW; Chang UI
Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
13. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Chang UI; Kim HW; Wie SH
Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
[TBL] [Abstract][Full Text] [Related]
14. Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
Lim SK; Park IW; Lee WG; Kim HK; Choi YH
Yonsei Med J; 2012 Jan; 53(1):164-71. PubMed ID: 22187248
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
[TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological characteristics of female patients with acute pyelonephritis who experienced urinary tract infections within the previous year.
Yoon C; Kim J; Jang W; Ko JW; Kim J; Pai H; Lee Y; Kim B
J Infect Public Health; 2024 Feb; 17(2):349-358. PubMed ID: 38198967
[TBL] [Abstract][Full Text] [Related]
17. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
18. [Acute complicated and uncomplicated pyelonephritis in the emergency department: process-of-care indicators and outcomes].
Delgado Vicente M; Lecaroz Agara MC; Barrios Andrés JL; Canut Blasco A
Emergencias; 2017 Feb; 29(1):27-32. PubMed ID: 28825265
[TBL] [Abstract][Full Text] [Related]
19. Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.
Chang UI; Kim HW; Wie SH
Antimicrob Agents Chemother; 2015 May; 59(5):2488-95. PubMed ID: 25645837
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).
Talan DA; Takhar SS; Krishnadasan A; Abrahamian FM; Mower WR; Moran GJ;
Emerg Infect Dis; 2016 Sep; 22(9):1594-603. PubMed ID: 27532362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
